ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Adult Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 79

$926K Total Retail Price of All Prescriptions

Rank: 2 out of 79

611 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

11% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $110 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 974 692 1 1
SIMVASTATIN 606 402 2 3
METOPROLOL TARTRATE 574 451 3 7
AMLODIPINE BESYLATE 447 373 4 4
LISINOPRIL 403 272 5 2
HYDROCHLOROTHIAZIDE 398 308 6 11
FUROSEMIDE 374 284 7 8
OMEPRAZOLE 355 214 8 10
METFORMIN HCL 322 184 9 16
HYDROCODONE-ACETAMINOPHEN 284 127 S3 10 9
WARFARIN SODIUM 283 265 11 5
GABAPENTIN 260 194 12 13
ATORVASTATIN CALCIUM 248 220 13 17
ENALAPRIL MALEATE 232 183 14 53
ATENOLOL 203 159 15 29
POTASSIUM CHLORIDE 197 139 16 31
TRAMADOL HCL 195 131 17 14
PRAVASTATIN SODIUM 195 171 17 15
LOSARTAN POTASSIUM 185 171 19 21
RANITIDINE HCL 178 119 20 44
SERTRALINE HCL 168 130 21 34
LOVASTATIN 161 114 22 56
CITALOPRAM HBR 155 115 23 41
CRESTOR 153 113 24 24
MELOXICAM 151 133 25 59
METOPROLOL SUCCINATE 144 119 26 22
ALENDRONATE SODIUM 137 92 27 30
ZOLPIDEM TARTRATE 130 88 28 18
DIOVAN 128 107 29 54
CYMBALTA 119 38 30 28
PROAIR HFA 116 75 31 37
TERAZOSIN HCL 113 113 32 84
DIGOXIN 112 86 33 85
SPIRONOLACTONE 110 79 34 87
PANTOPRAZOLE SODIUM 100 72 35 33
LOSARTAN-HYDROCHLOROTHIAZIDE 100 84 35 91
QUINAPRIL HCL 98 91 37 92
NAPROXEN 98 60 37 92
OXYCODONE-ACETAMINOPHEN 97 54 S2 39 20
RISPERIDONE 96 87 40 58
CELEBREX 95 87 41 96
NEXIUM 93 39 42 42
CYCLOBENZAPRINE HCL 91 28 R 43 51
EVISTA 89 85 44 98
LANSOPRAZOLE 88 25 45 99
SPIRIVA 87 64 46 27
RAMIPRIL 86 73 47 100
JANUVIA 83 37 48 66
OXYCODONE HCL-ACETAMINOPHEN 83 43 S2 48 46
BENAZEPRIL HCL 83 69 48 101
VYTORIN 82 43 51 102
CLOPIDOGREL 78 58 52 105
ADVAIR DISKUS 76 60 53 38
CARVEDILOL 72 51 54 49
DIOVAN HCT 70 63 55 111
PLAVIX 70 51 55 111
IBUPROFEN 69 38 57 80
CIPROFLOXACIN HCL 69 42 57 68
ALLOPURINOL 69 65 57 76
AZITHROMYCIN 69 47 57 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 52 61 74
ISOSORBIDE MONONITRATE ER 66 45 62 74
GEMFIBROZIL 66 51 62 114
GLIPIZIDE 65 48 64 81
ACTONEL 64 62 65 117
FLUOXETINE HCL 62 45 66 118
POLYETHYLENE GLYCOL 3350 61 37 67 121
BENICAR 61 58 67 121
GLIMEPIRIDE 60 40 69 124
GLIPIZIDE XL 57 50 70 126
PAROXETINE HCL 57 45 70 126
FENOFIBRATE 57 32 70 126
COMBIVENT 56 33 73 73
VERAPAMIL ER 56 40 73 130
ROPINIROLE HCL 55 47 75 132
FENTANYL 55 29 S2 75 19
OXYCODONE HCL 55 14 S2 75 6
SYNTHROID 53 48 78 137
ESCITALOPRAM OXALATE 52 21 79 138
LANTUS 50 27 80 63
NABUMETONE 50 0 80 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.